LLY compared with NCEL: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

NCELNewcelX Ltd.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

NCELNewcelX Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,419.27

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

NCELNewcelX Ltd.

2.41▼−8.71%· post 2.46

ClosedNov 4 '26

Mkt cap$9.8MRevenue—Revenue—

Compare

ClosedNov 4 '26

LLYELI Lilly & Co

NCELNewcelX Ltd.

1,417.89▲+0.60%post 1,419.27

Price

2.41▼−8.71%post 2.46

$1.3T

Mkt cap

$9.8M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,417.89▲+0.60%vsNCEL2.41▼−8.71%ClosedNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NCEL: latest quarter not drawable.Method ›

Price

rebased to 0%

LLY, solidNCEL, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only NCEL 3

ELDNEledon Pharmaceuticalscustomer

PLURPlurisupplier

—Ramot at Tel Aviv Universityunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR